Literature DB >> 26384764

Changes in Right Ventricular Function with Exercise in Healthy Subjects: Optimal Parameters and Effects of Gender and Age.

Ee-May Chia1, Calvin H C Hsieh2, Phuong Pham1, Jane Vidaic1, Wei Xuan1, Dominic Leung1, Liza Thomas3.   

Abstract

BACKGROUND: Right ventricular (RV) function augments with exercise, and loss of this adaptive ability often determines symptoms. Reports on exercise-related changes in RV function in healthy subjects are sparse. In this study, healthy volunteers were prospectively recruited, and changes in RV function with exercise were examined, optimal parameters determined, and the effects of gender and age examined.
METHODS: Treadmill exercise stress echocardiography with concurrent expired gas analysis was performed in 121 healthy volunteers. Parameters of RV systolic function (RV fractional area change, Doppler tissue s' velocity, and systolic strain and strain rate) and diastolic function (peak E and A velocity, Doppler tissue e', a' and early and late diastolic strain rate) were evaluated at baseline and after exercise, with the difference (Δ) being systolic and diastolic reserve. Changes in pulmonary arterial pressure (PAP) was measured when accurate estimation was possible.
RESULTS: Most systolic functional parameters were augmented with exercise. However, systolic augmentation decreased with age (Δs': r = -0.31, P < .01; Δ strain: r = -0.28, P = .008; Δ systolic strain rate: r = -0.31, P < .01). Similar changes were observed with diastolic function (Δe': r = -0.33, P < .01; Δ early diastolic strain rate r = -0.20, P = .04). In the subgroup with PAP measurements, ΔPAP (r = 0.32, P < .01) increased with age. Men had greater augmentation of systolic reserve, but differences were negated when corrected for workload. S' velocity was the most robust measure of RV systolic function.
CONCLUSIONS: There is a modest yet significant reduction in RV systolic and diastolic reserve with age, with an increase in PAP. S' velocity is a robust and feasible measure that should be considered given the increasing use of stress testing to evaluate RV function. Crown
Copyright © 2015. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Exercise; Pulmonary arterial pressure; RV diastolic function; RV systolic function

Mesh:

Year:  2015        PMID: 26384764     DOI: 10.1016/j.echo.2015.08.006

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  5 in total

1.  Right Ventricular Contractile Reserve Is Impaired in Children and Adolescents With Repaired Tetralogy of Fallot: An Exercise Strain Imaging Study.

Authors:  Shivani M Bhatt; Yan Wang; Okan U Elci; Elizabeth Goldmuntz; Michael McBride; Stephen Paridon; Laura Mercer-Rosa
Journal:  J Am Soc Echocardiogr       Date:  2018-09-27       Impact factor: 5.251

2.  Systematic Review and Regression Modeling of the Effects of Age, Body Size, and Exercise on Cardiovascular Parameters in Healthy Adults.

Authors:  Aseem Pradhan; John Scaringi; Patrick Gerard; Ross Arena; Jonathan Myers; Leonard A Kaminsky; Ethan Kung
Journal:  Cardiovasc Eng Technol       Date:  2021-10-19       Impact factor: 2.305

3.  Non-invasive imaging of global and regional cardiac function in pulmonary hypertension.

Authors:  Tim Crowe; Geeshath Jayasekera; Andrew J Peacock
Journal:  Pulm Circ       Date:  2017-10-24       Impact factor: 3.017

4.  The association between right ventricular free wall strain and exercise capacity for health check-up subjects.

Authors:  Wei-Ting Chang; Yen-Wen Liu; Ping-Yen Liu; Chih-Hsin Hsu; Wei-Chuan Tsai
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

5.  Right Ventricle Mechanics and Function during Stress in Patients with Asymptomatic Primary Moderate to Severe Mitral Regurgitation and Preserved Left Ventricular Ejection Fraction.

Authors:  Rūta Žvirblytė; Ieva Merkytė; Eglė Tamulėnaitė; Agnė Saniukaitė; Vaida Mizarienė; Eglė Ereminienė; Jolanta Justina Vaškelytė
Journal:  Medicina (Kaunas)       Date:  2020-06-20       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.